[1]
“REAL-WORLD TREATMENT ADHERENCE AND OVERALL SURVIVAL IN CANCER PATIENTS RECEIVING PEMBROLIZUMAB THROUGH A PATIENT ASSISTANCE PROGRAM AT MILITARY HOSPITAL 175”, YHCĐ, vol. 67, no. Số CĐ12- Bệnh viện Ung bướu Nghệ An, Aug. 2026, doi: 10.52163/yhc.v67iCD12.6167.